| mRNA |
CIL55 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
1e-05 |
| mRNA |
BMS-536924 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
2e-05 |
| mRNA |
NVP-BEZ235 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-05 |
| mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
3e-05 |
| mRNA |
avrainvillamide |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-05 |
| mRNA |
HG-6-64-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
5e-05 |
| mRNA |
FSC231 |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
6e-05 |
| mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0001 |
| mRNA |
lenalidomide |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
0.0001 |